← Back to Analyst Consensus 
VCYT Buy
VERACYTE, INC.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 15, 2026 | Freedom Capital Markets | maintain | Buy → Buy | — | 43% |
| Sep 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Aug 4, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Stephens & Co. | maintain | Overweight → Overweight | — | 54% |
| Aug 4, 2026 | Morgan Stanley | maintain | Underweight → Underweight | — | 54% |
| Aug 3, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Jul 31, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 30, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 15, 2026 | Piper Sandler | initiate | Overweight → Overweight | — | 54% |
| Jul 14, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Jul 9, 2026 | Morgan Stanley | maintain | Underweight → Underweight | — | 54% |
| Jun 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 1, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| May 28, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 6, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| May 6, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 20, 2026 | Canaccord Genuity | maintain | Hold → Hold | — | 48% |
| Apr 13, 2026 | Jefferies | initiate | — → Buy | — | 52% |
| Apr 1, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Mar 30, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 6, 2026 | Morgan Stanley | maintain | Underweight → Underweight | — | 54% |
| Feb 26, 2026 | Needham | maintain | Buy → Buy | $48 | 50% |
| Jan 5, 2026 | Guggenheim | maintain | Buy → Buy | $50 | 52% |
| Dec 2, 2025 | Morgan Stanley | maintain | Underweight → Underweight | $48 | 54% |
| Nov 11, 2025 | Morgan Stanley | maintain | Underweight → Underweight | $40 | 54% |
| Nov 5, 2025 | UBS | maintain | Buy → Buy | $48 | 54% |
| Nov 5, 2025 | Canaccord Genuity | maintain | Hold → Hold | $43 | 48% |
| Nov 5, 2025 | Guggenheim | maintain | Buy → Buy | $45 | 52% |
| Nov 5, 2025 | Needham | maintain | Buy → Buy | $44 | 50% |
| Oct 20, 2025 | Canaccord Genuity | initiate | — → Hold | $40 | 48% |
| Oct 17, 2025 | Freedom Capital Markets | initiate | — → Buy | $45 | 43% |
| May 8, 2025 | UBS | maintain | Buy → Buy | $42 | 54% |
| May 8, 2025 | Needham | maintain | Buy → Buy | $41 | 50% |
| Apr 9, 2025 | Guggenheim | maintain | Buy → Buy | $37 | 52% |
| Mar 26, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $45 | 54% |
| Mar 20, 2025 | Craig-Hallum | initiate | — → Buy | $45 | 54% |
| Feb 25, 2025 | UBS | maintain | Buy → Buy | $49 | 54% |
| Feb 25, 2025 | Guggenheim | reiterate | Buy → Buy | $45 | 52% |
| Feb 25, 2025 | Needham | reiterate | Buy → Buy | $51 | 50% |
| Jan 29, 2025 | Needham | maintain | Buy → Buy | $51 | 50% |
| Dec 5, 2024 | Goldman Sachs | downgrade | Buy → Neutral | $37 | 54% |
| Nov 18, 2024 | Morgan Stanley | maintain | Underweight → Underweight | $28 | 54% |
| Nov 8, 2024 | Scotiabank | maintain | Sector Outperform → Sector Outperform | $44 | 55% |
| Nov 7, 2024 | Goldman Sachs | maintain | Buy → Buy | $38 | 54% |
| Nov 7, 2024 | UBS | maintain | Buy → Buy | $46 | 54% |
| Nov 7, 2024 | Needham | maintain | Buy → Buy | $44 | 50% |
| Oct 17, 2024 | Leerink Partners | maintain | Outperform → Outperform | $40 | 51% |
| Oct 16, 2024 | UBS | initiate | — → Buy | $43 | 54% |
| Oct 10, 2024 | Guggenheim | initiate | — → Buy | $40 | 52% |
| Aug 28, 2024 | Needham | maintain | Buy → Buy | $37 | 50% |
Price Target Trend
May 20, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days